The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorbachev, A. V.
Right arrow Articles by Fairchild, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorbachev, A. V.
Right arrow Articles by Fairchild, R. L.
The Journal of Immunology, 2004, 173: 2443-2452.
Copyright © 2004 by The American Association of Immunologists

CD40 Engagement Enhances Antigen-Presenting Langerhans Cell Priming of IFN-{gamma}-Producing CD4+ and CD8+ T Cells Independently of IL-121

Anton V. Gorbachev2,* and Robert L. Fairchild*,{dagger},{ddagger}

* Department of Immunology and {dagger} Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195; and {ddagger} Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106

The delivery of CD40 signaling to APCs during T cell priming enhances many T cell-mediated immune responses. Although CD40 signaling up-regulates APC production of IL-12, the impact of this increased production on T cell priming is unclear. In this study an IL-12-independent T cell-mediated immune response, contact hypersensitivity (CHS), was used to further investigate the effect of CD40 ligation on the phenotypic development of Ag-specific CD4+ and CD8+ T cells. Normally, sensitization for CHS responses induces hapten-specific CD4+ T cells producing type 2 cytokines and CD8+ T cells producing IFN-{gamma}. Treatment of mice with agonist anti-CD40 mAb during sensitization with the hapten 2,4-dinitrofluorobenzene resulted in CHS responses of increased magnitude and duration. These augmented responses in anti-CD40 Ab-treated mice correlated with increased numbers of hapten-specific CD4+ and CD8+ T cells producing IFN-{gamma} in the skin draining lymph nodes. Identical results were observed using IL-12–/– mice, indicating that CD40 ligation promotes CHS responses and development of IFN-{gamma}-producing CD4+ and CD8+ T cells in the absence of IL-12. Engagement of CD40 on hapten-presenting Langerhans cells (hpLC) up-regulated the expression of both class I and class II MHC and promoted hpLC migration into the T cell priming site. These results indicate that hpLC stimulated by CD40 ligation use a mechanism distinct from increased IL-12 production to promote Ag-specific T cell development to IFN-{gamma}-producing cells.




This article has been cited by other articles:


Home page
JEMHome page
S. F. Martin, J. C. Dudda, E. Bachtanian, A. Lembo, S. Liller, C. Durr, M. M. Heimesaat, S. Bereswill, G. Fejer, R. Vassileva, et al.
Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity
J. Exp. Med., September 1, 2008; 205(9): 2151 - 2162.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. D. Kish, A. V. Gorbachev, and R. L. Fairchild
Regulatory function of CD4+CD25+ T cells from Class II MHC-deficient mice in contact hypersensitivity responses
J. Leukoc. Biol., July 1, 2007; 82(1): 85 - 92.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. P. Hewitson, P. A. Hamblin, and A. P. Mountford
In the Absence of CD154, Administration of Interleukin-12 Restores Th1 Responses but Not Protective Immunity to Schistosoma mansoni
Infect. Immun., July 1, 2007; 75(7): 3539 - 3547.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kelschenbach, R. A. Barke, and S. Roy
Morphine Withdrawal Contributes to Th Cell Differentiation by Biasing Cells Toward the Th2 Lineage
J. Immunol., August 15, 2005; 175(4): 2655 - 2665.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Li, A. C. Grover, E. J. Donald, A. Carr, J. Yu, J. Whitfield, M. Nelson, N. Takeshita, and A. E. Chang
Simultaneous Targeting of CD3 on T Cells and CD40 on B or Dendritic Cells Augments the Antitumor Reactivity of Tumor-Primed Lymph Node Cells
J. Immunol., August 1, 2005; 175(3): 1424 - 1432.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.